WGHA members have received millions of dollars from the American Recovery and Reinvestment Act of 2009 (ARRA). ARRA was signed into law on February 17, 2009 by President Barack Obama, with the purpose of creating new jobs, spurring economic activity, and fostering accountability and transparency in government spending. As a growing sector, global health was positioned with the infrastructure neccessary to build on existing jobs and projects. In turn, over $85.8 million was given to WGHA executive partner organizations, with a good portion of these awards directed to global health activities.

Fred Hutchinson Cancer Research Center has received over 60 research grants totalling nearly $40.4 million. Projects undertaken with these funds include developing assays to measure proteins expressed in cancer, identifying genetic varians associated with cancer, and reducing patient risk with cord blood transplantation. Funds were distributed for a project focusing on the development of a center for comparative-effectiveness research in cancer, which will create tools to aid researchers in determining which proposed trials will have the most clinical benefit for patients.

Infectious Disease Research Institute has received $432,300 in funding from the National Institutes of Health to support IDRI's efforts to better understand the mechanisms of tuberculosis and ultimately identify new drugs to treat it. While resistance to current treatments is spreading dangerously, no truly novel TB drug has been developed for use in over 40 years. IDRI believes we urgently need new and more effective drugs to fight against TB. This funding is essential in harnessing the most promising science to discover new TB drugs as quickly as possible, so as to address this global emergency affecting millions of lives.

Institute for Systems Biology has received about $5 million in Recovery Act funding. $4.6 million will be directed to completing an atlas of human peptides and a little more than $400,000 will be aimed at researching how environmental and genetic factors combine to drive asthma attacks. The funding will allow ISB to conduct important research into human health and disease that might not have occurred otherwise.

Pacific Northwest National Laboratory has received some stimulus funding and is dedicating it to the update of capital equipment and instrumentation for their Environmental Molecular Sciences Laboratory (EMSL), the US Department of Energy User Facility located at PNNL's campus.

PATH has received around $250,000 over two years, to supplement a Diagnostics Center grant. The funds will be used to provide complete human resource capability.

Seattle Biomedical Research Institute has received eleven stimulus grants totalling $3.8 million. These grants cover a variety of research including: malaria, tuberculosis, candidiasis, toxoplasmosis, as well as funds for the afterschool science education program, BioQuest Academy. This funding allowes SBRI to increase staff and expand research.

Seattle Children's has received nearly $6 million in funding to be used for various projects focused in many areas such as immunology and pediatric infections.

Washington State University has received 42 awards totaling more than $30 million under the Recovery Act. Grant monies are funding critical, groundbreaking research, and stimulating the local economy through the creation of jobs. WSU believes that these federal dollars have had a significant impact on work underway at the university.